- SGMO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Sangamo Therapeutics (SGMO) S-3ASRAutomatic shelf registration
Filed: 25 Feb 14, 12:00am
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3ASRNo. 333-00000) and related Prospectus of Sangamo BioSciences, Inc. for the registration of common stock, preferred stock, debt securities, warrants to purchase common stock and warrants to purchase preferred stock and to the incorporation by reference therein of our reports dated February 24, 2014, with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2013, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Jose, California
February 24, 2014